ALX-0651

CAT: 0804-HY-P991647Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991647Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ALX-0651 is a biparatopic humanized monoclonal antibody inhibitor targeting CXCR4. ALX-0651 inhibits hematopoietic stem cell trafficking, tumor progression and metastasis. ALX-0651 can be used for non-Hodgkin’s lymphoma and multiple myeloma research[1].
UNSPSC
12352100
Target
CXCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]De Pauw T, et al. Current status and future expectations of nanobodies in oncology trials. Expert Opin Investig Drugs. 2023 Jul-Dec;32 (8) :705-721.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CXCR4

Popular Products